Disclosures for "Evaluation Of Additive Neuroprotective Effect of Combination Therapy For Parkinson's Disease Using in Vitro Models"
-
Dr. Shtilbans has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Shtilbans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal Pharmaceuticals. The institution of Dr. Shtilbans has received research support from NIH. The institution of Dr. Shtilbans has received research support from Praxis Precision Medicines.
-
Dr. Esneault has received personal compensation for serving as an employee of Porsolt.
-
Mr. SIMON has nothing to disclose.
-
Dr. Mazzulli has stock in Lysosomal Therapeutics Inc.
-
Mr. Quiriconi has nothing to disclose.
-
Dr. Rom has nothing to disclose.
-
Mr. Reintsch has nothing to disclose.
-
Dr. Piscopo has nothing to disclose.
-
Ms. Krahn has nothing to disclose.
-
Dr. Durcan has nothing to disclose.